Literature DB >> 19385065

Progressive thalamocortical neuron loss in Cln5 deficient mice: Distinct effects in Finnish variant late infantile NCL.

Carina von Schantz1, Catherine Kielar, Stine N Hansen, Charlie C Pontikis, Noreen A Alexander, Outi Kopra, Anu Jalanko, Jonathan D Cooper.   

Abstract

Finnish variant LINCL (vLINCL(Fin)) is the result of mutations in the CLN5 gene. To gain insights into the pathological staging of this fatal pediatric disorder, we have undertaken a stereological analysis of the CNS of Cln5 deficient mice (Cln5-/-) at different stages of disease progression. Consistent with human vLINCL(Fin), these Cln5-/- mice displayed a relatively late onset regional atrophy and generalized cortical thinning and synaptic pathology, preceded by early and localized glial responses within the thalamocortical system. However, in marked contrast to other forms of NCL, neuron loss in Cln5-/- mice began in the cortex and only subsequently occurred within thalamic relay nuclei. Nevertheless, as in other NCL mouse models, this progressive thalamocortical neuron loss was still most pronounced within the visual system. These data provide unexpected evidence for a distinctive sequence of neuron loss in the thalamocortical system of Cln5-/- mice, diametrically opposed to that seen in other forms of NCL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19385065      PMCID: PMC2704904          DOI: 10.1016/j.nbd.2009.02.001

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  37 in total

1.  CLN-1 and CLN-5, genes for infantile and variant late infantile neuronal ceroid lipofuscinoses, are expressed in the embryonic human brain.

Authors:  O Heinonen; T Salonen; A Jalanko; L Peltonen; A Copp
Journal:  J Comp Neurol       Date:  2000-10-23       Impact factor: 3.215

Review 2.  The neuronal ceroid-lipofuscinoses.

Authors:  Matti Haltia
Journal:  J Neuropathol Exp Neurol       Date:  2003-01       Impact factor: 3.685

3.  Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth.

Authors:  Susan L Cotman; Vladimir Vrbanac; Lori-Anne Lebel; Richard L Lee; Kevin A Johnson; Leah-Rae Donahue; Allison M Teed; Kristen Antonellis; Roderick T Bronson; Terry J Lerner; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2002-10-15       Impact factor: 6.150

4.  Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein.

Authors:  Juha Isosomppi; Jouni Vesa; Anu Jalanko; Leena Peltonen
Journal:  Hum Mol Genet       Date:  2002-04-15       Impact factor: 6.150

Review 5.  Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis.

Authors:  Jonathan D Cooper
Journal:  Curr Opin Neurol       Date:  2003-04       Impact factor: 5.710

6.  A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration.

Authors:  David E Sleat; Jennifer A Wiseman; Mukarram El-Banna; Kwi-Hye Kim; Qinwen Mao; Sandy Price; Shannon L Macauley; Richard L Sidman; Michael M Shen; Qi Zhao; Marco A Passini; Beverly L Davidson; Gregory R Stewart; Peter Lobel
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

7.  A new large animal model of CLN5 neuronal ceroid lipofuscinosis in Borderdale sheep is caused by a nucleotide substitution at a consensus splice site (c.571+1G>A) leading to excision of exon 3.

Authors:  Tony Frugier; Nadia L Mitchell; Imke Tammen; Peter J Houweling; Donald G Arthur; Graham W Kay; Otto P van Diggelen; Robert D Jolly; David N Palmer
Journal:  Neurobiol Dis       Date:  2007-09-29       Impact factor: 5.996

8.  Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis.

Authors:  Ellen Bible; Praveena Gupta; Sandra L Hofmann; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2004-07       Impact factor: 5.996

9.  Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3.

Authors:  Jouni Vesa; Mark H Chin; Kathrin Oelgeschläger; Juha Isosomppi; Esteban C DellAngelica; Anu Jalanko; Leena Peltonen
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

10.  Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation.

Authors:  Charlie C Pontikis; Claire V Cella; Nisha Parihar; Ming J Lim; Shubhodeep Chakrabarti; Hannah M Mitchison; William C Mobley; Payam Rezaie; David A Pearce; Jonathan D Cooper
Journal:  Brain Res       Date:  2004-10-15       Impact factor: 3.252

View more
  16 in total

1.  [NCL in animal models].

Authors:  K Rüther
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

2.  An EEG Investigation of Sleep Homeostasis in Healthy and CLN5 Batten Disease Affected Sheep.

Authors:  Nicholas Perentos; Amadeu Q Martins; Robin J M Cumming; Nadia L Mitchell; David N Palmer; Stephen J Sawiak; A Jennifer Morton
Journal:  J Neurosci       Date:  2016-08-03       Impact factor: 6.167

Review 3.  Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis.

Authors:  Konrad Kaminiów; Sylwia Kozak; Justyna Paprocka
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

Review 4.  A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.

Authors:  I Basak; H E Wicky; K O McDonald; J B Xu; J E Palmer; H L Best; S Lefrancois; S Y Lee; L Schoderboeck; S M Hughes
Journal:  Cell Mol Life Sci       Date:  2021-04-01       Impact factor: 9.261

Review 5.  Glial Dysfunction and Its Contribution to the Pathogenesis of the Neuronal Ceroid Lipofuscinoses.

Authors:  Keigo Takahashi; Hemanth R Nelvagal; Jenny Lange; Jonathan D Cooper
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.086

6.  Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice.

Authors:  Yoshinori Tanaka; James K Chambers; Takashi Matsuwaki; Keitaro Yamanouchi; Masugi Nishihara
Journal:  Acta Neuropathol Commun       Date:  2014-07-15       Impact factor: 7.801

7.  Exacerbated neuronal ceroid lipofuscinosis phenotype in Cln1/5 double-knockout mice.

Authors:  Tea Blom; Mia-Lisa Schmiedt; Andrew M Wong; Aija Kyttälä; Jarkko Soronen; Matti Jauhiainen; Jaana Tyynelä; Jonathan D Cooper; Anu Jalanko
Journal:  Dis Model Mech       Date:  2012-10-12       Impact factor: 5.758

8.  A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease.

Authors:  Jeremy P Morgan; Helen Magee; Andrew Wong; Tarah Nelson; Bettina Koch; Jonathan D Cooper; Jill M Weimer
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

9.  Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV.

Authors:  Yulia Grishchuk; Sarmi Sri; Nikita Rudinskiy; Weiyuan Ma; Katherine G Stember; Matthew W Cottle; Ellen Sapp; Marian Difiglia; Alona Muzikansky; Rebecca A Betensky; Andrew M S Wong; Brian J Bacskai; Bradley T Hyman; Raymond J Kelleher; Jonathan D Cooper; Susan A Slaugenhaupt
Journal:  Acta Neuropathol Commun       Date:  2014-09-09       Impact factor: 7.801

10.  Molecular neuropathology of the synapse in sheep with CLN5 Batten disease.

Authors:  Inês S Amorim; Nadia L Mitchell; David N Palmer; Stephen J Sawiak; Roger Mason; Thomas M Wishart; Thomas H Gillingwater
Journal:  Brain Behav       Date:  2015-10-09       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.